title: Brief report: severe symptoms of hyperhistaminemia after the treatment of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)
authors.affiliation: First Department of Internal Medicine, Niigata University School of Medicine, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Koike
authors.forename: W
authors.initials: W
authors.lastname: Tatewaki
authors.forename: A
authors.initials: A
authors.lastname: Aoki
authors.forename: H
authors.initials: H
authors.lastname: Yoshimoto
authors.forename: K
authors.initials: K
authors.lastname: Yagisawa
authors.forename: S
authors.initials: S
authors.lastname: Hashimoto
authors.forename: T
authors.initials: T
authors.lastname: Furukawa
authors.forename: H
authors.initials: H
authors.lastname: Saitoh
authors.forename: M
authors.initials: M
authors.lastname: Takahashi
authors.forename: L B
authors.initials: LB
authors.lastname: Yang
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D001491:Basophils; D001853:Bone Marrow / Q000473:pathology; D002454:Cell Differentiation / Q000187:drug effects; D006632:Histamine / Q000097:blood*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D007958:Leukocyte Count; D007964:Leukocytosis / Q000139:chemically induced; D008297:Male; D010437:Peptic Ulcer / Q000139:chemically induced; D014212:Tretinoin / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D014212:Tretinoin; D006632:Histamine